Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | tyrosyl-DNA phosphodiesterase 1 | Starlite/ChEMBL | No references |
Homo sapiens | polymerase (DNA directed) iota | Starlite/ChEMBL | No references |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Trypanosoma cruzi | tyrosyl-DNA Phosphodiesterase (Tdp1), putative | 0.008 | 0.1454 | 0.4374 |
Loa Loa (eye worm) | dihydrofolate reductase | 0.0381 | 1 | 1 |
Leishmania major | dihydrofolate reductase-thymidylate synthase | 0.0146 | 0.3323 | 1 |
Leishmania major | tyrosyl-DNA phosphodiesterase 1 | 0.008 | 0.1454 | 0.4374 |
Entamoeba histolytica | tyrosyl-DNA phosphodiesterase, putative | 0.008 | 0.1454 | 0.5 |
Echinococcus multilocularis | transcription factor Dp 1 | 0.0046 | 0.05 | 0.05 |
Schistosoma mansoni | fatty-acid amide hydrolase | 0.0236 | 0.5905 | 0.5905 |
Echinococcus granulosus | fatty acid amide hydrolase 1 | 0.0236 | 0.5905 | 0.5905 |
Echinococcus multilocularis | tyrosyl DNA phosphodiesterase 1 | 0.008 | 0.1454 | 0.1454 |
Echinococcus granulosus | fatty acid amide hydrolase 1 | 0.0236 | 0.5905 | 0.5905 |
Mycobacterium ulcerans | dihydrofolate reductase DfrA | 0.0381 | 1 | 1 |
Toxoplasma gondii | bifunctional dihydrofolate reductase-thymidylate synthase | 0.0146 | 0.3323 | 0.5 |
Echinococcus granulosus | transcription factor Dp 1 | 0.0046 | 0.05 | 0.05 |
Trypanosoma cruzi | tyrosyl-DNA Phosphodiesterase (Tdp1), putative | 0.008 | 0.1454 | 0.4374 |
Schistosoma mansoni | dihydrofolate reductase | 0.0381 | 1 | 1 |
Trypanosoma brucei | tyrosyl-DNA Phosphodiesterase (Tdp1), putative | 0.008 | 0.1454 | 0.4374 |
Trypanosoma brucei | dihydrofolate reductase-thymidylate synthase | 0.0146 | 0.3323 | 1 |
Loa Loa (eye worm) | tyrosyl-DNA phosphodiesterase | 0.008 | 0.1454 | 0.1454 |
Loa Loa (eye worm) | hypothetical protein | 0.0236 | 0.5905 | 0.5905 |
Echinococcus granulosus | tyrosyl DNA phosphodiesterase 1 | 0.008 | 0.1454 | 0.1454 |
Echinococcus granulosus | dihydrofolate reductase | 0.0381 | 1 | 1 |
Echinococcus multilocularis | dihydrofolate reductase | 0.0381 | 1 | 1 |
Mycobacterium leprae | DIHYDROFOLATE REDUCTASE DFRA (DHFR) (TETRAHYDROFOLATE DEHYDROGENASE) | 0.0381 | 1 | 1 |
Chlamydia trachomatis | dihydrofolate reductase | 0.0381 | 1 | 1 |
Trypanosoma cruzi | dihydrofolate reductase-thymidylate synthase | 0.0146 | 0.3323 | 1 |
Brugia malayi | Dihydrofolate reductase | 0.0381 | 1 | 1 |
Plasmodium vivax | bifunctional dihydrofolate reductase-thymidylate synthase, putative | 0.0146 | 0.3323 | 1 |
Brugia malayi | Tyrosyl-DNA phosphodiesterase family protein | 0.008 | 0.1454 | 0.1454 |
Wolbachia endosymbiont of Brugia malayi | aspartyl/glutamyl-tRNA amidotransferase subunit A | 0.0029 | 0 | 0.5 |
Echinococcus multilocularis | fatty acid amide hydrolase 1 | 0.0236 | 0.5905 | 0.5905 |
Treponema pallidum | aspartyl/glutamyl-tRNA amidotransferase subunit A | 0.0029 | 0 | 0.5 |
Echinococcus multilocularis | fatty acid amide hydrolase 1 | 0.0236 | 0.5905 | 0.5905 |
Mycobacterium tuberculosis | Dihydrofolate reductase DfrA (DHFR) (tetrahydrofolate dehydrogenase) | 0.0381 | 1 | 1 |
Schistosoma mansoni | tyrosyl-DNA phosphodiesterase | 0.008 | 0.1454 | 0.1454 |
Brugia malayi | amidase | 0.0236 | 0.5905 | 0.5905 |
Plasmodium falciparum | bifunctional dihydrofolate reductase-thymidylate synthase | 0.0146 | 0.3323 | 1 |
Schistosoma mansoni | amidase | 0.0236 | 0.5905 | 0.5905 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Potency (functional) | 0.5012 uM | PUBCHEM_BIOASSAY: qHTS for Inhibitors of TGF-b: Cytotox Counterscreen. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588855, AID588860] | ChEMBL. | No reference |
Potency (binding) | = 4.4668 um | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Tyrosyl-DNA Phosphodiesterase (TDP1). (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 10 uM | PUBCHEM_BIOASSAY: qHTS for Inhibitors of Polymerase Iota. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588623] | ChEMBL. | No reference |
Potency (functional) | 16.5113 uM | PUBCHEM_BIOASSAY: Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 96 hour incubation. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488745, AID488752, AID488774, AID504848, AID504850] | ChEMBL. | No reference |
Potency (functional) | 22.3872 uM | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Histone Lysine Methyltransferase G9a. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504404] | ChEMBL. | No reference |
Potency (functional) | = 25.1189 um | PUBCHEM_BIOASSAY: qHTS Fluorescence Polarization Assay for Inhibitors of MLL CXXC domain - DNA interaction. (Class of assay: confirmatory) [Related pubchem assays: 2698 (Summary assay.)] | ChEMBL. | No reference |
Potency (functional) | = 25.1189 um | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors Targeting the Menin-MLL Interaction in MLL Related Leukemias: Competition With Texas Red Labeled MLL-derived Mutant Peptide. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 26.6795 uM | PubChem BioAssay. qHTS for Inhibitors of PLK1-PDB (polo-like kinase 1 - polo-box domain): Primary Screen. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 28.1838 uM | PubChem BioAssay. qHTS for Inhibitors of WRN Helicase. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 79.4328 uM | PUBCHEM_BIOASSAY: Inhibitors of the vitamin D receptor (VDR): qHTS. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504855] | ChEMBL. | No reference |
Potency (functional) | 79.4328 uM | PUBCHEM_BIOASSAY: qHTS for Inhibitors of Polymerase Eta. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588636] | ChEMBL. | No reference |
Species name | Source | Reference | Is orphan |
---|---|---|---|
Plasmodium falciparum | ChEMBL23 | ||
Homo sapiens | ChEMBL23 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.